dipyrromethene and Staphylococcal-Infections

dipyrromethene has been researched along with Staphylococcal-Infections* in 1 studies

Other Studies

1 other study(ies) available for dipyrromethene and Staphylococcal-Infections

ArticleYear
Unadulterated BODIPY nanoparticles as light driven antibacterial agents for treating bacterial infections and promoting wound healing.
    Journal of photochemistry and photobiology. B, Biology, 2023, Volume: 241

    Antimicrobial photodynamic therapy (aPDT) is an effective strategy to eliminate bacteria without inducing bacterial resistance. As typical aPDT photosensitizers, most of boron-dipyrromethene (BODIPY) are hydrophobic, and nanometerization is imperative to render them dispersible in physiological media. Recently, carrier-free nanoparticles (NPs) are formed via the self-assembly of BODIPYs without the help of any surfactants or auxiliaries, arousing people's interest. So as to fabricate carrier-free NPs, BODIPYs usually need to be derived into dimers, trimers, or amphiphiles through complex reactions. Few unadulterated NPs were obtained from BODIPYs with precise structures. Herein, BNP1-BNP3 were synthesized by the self-assembly of BODIPY, which showed excellent anti-Staphylococcus aureus ability. Among them, BNP2 could effectively fight bacterial infections and promote wound healing in vivo.

    Topics: Anti-Bacterial Agents; Boron; Humans; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Staphylococcal Infections; Wound Healing

2023